Related Experiment Videos
Follow-up after partial or total nephrectomy for renal cell carcinoma
1Department of Urology, Wayne State University School of Medicine, Detroit, Michigan.
The Urologic Clinics of North America
|November 1, 1994
Summary
Salvage therapy options for recurrent renal cell carcinoma are limited. Early symptom investigation and tailored follow-up schedules can help minimize morbidity from metastases.
Area of Science:
- Oncology
- Urology
Background:
- Recurrent renal cell carcinoma presents limited salvage therapy options.
- Palliative care is often the primary approach for advanced disease.
Purpose of the Study:
- To outline available salvage therapy strategies for recurrent renal cell carcinoma.
- To propose an optimized follow-up schedule for patients with recurrent renal cell carcinoma.
Main Methods:
- Review of current salvage treatment modalities.
- Development of a structured follow-up protocol.
Main Results:
- Limited but specific interventions like resection of solitary metastases or contralateral tumors are possible.
- Systemic biologic response modifier therapy may be an option for select patients.
Conclusions:
- Salvage therapy for recurrent renal cell carcinoma is challenging, necessitating careful patient selection.
- A proactive follow-up strategy focusing on early symptom detection is crucial for managing potential metastases and improving patient outcomes.